As of November 6, 2026, retatrutide remains investigational in the United States. Published trial findings and regulatory approval are different milestones.
Research status and evidence
Trial results describe people, protocols and time points that investigators studied. A regulatory decision evaluates a broader evidence package and determines the terms for an approved use.
How to interpret the evidence
When a status claim matters, check its date and the regulator or study sponsor. Terms used by retailers are separate from a regulator’s determination.
Start with the intervention name and receptor targets, then follow the links to the original trial if you want to check what was measured in people.